Cargando…

Ivermectin: potential candidate for the treatment of Covid 19

Detalles Bibliográficos
Autores principales:	Gupta, Dhyuti, Sahoo, Ajaya Kumar, Singh, Alok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321032/ https://www.ncbi.nlm.nih.gov/pubmed/32615072 http://dx.doi.org/10.1016/j.bjid.2020.06.002

Ejemplares similares

The Use of Ivermectin in the Treatment of COVID-19
por: Shukla, Ajay Kumar, et al.
Publicado: (2023)

The outlook of doctors toward telemedicine: A cross-sectional study of knowledge, awareness, and attitude in central India
por: Singh, Alok, et al.
Publicado: (2021)

Retrospective Analysis of Drug Prescription Statistics in a Tertiary Care Center in India: Recommendations for Promoting Prudent Utilization of Drugs
por: Sahoo, Ajaya Kumar, et al.
Publicado: (2020)

Ivermectin and COVID-19
por: Wiwanitkit, Viroj
Publicado: (2021)

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
por: Shukla, Dr. Ajay Kumar, et al.
Publicado: (2021)

The Profile of Use of Rituximab in Tertiary Care Hospitals of Central India
por: Singh, Alok, et al.
Publicado: (2022)

Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19()
por: Portmann-Baracco, Arianna, et al.
Publicado: (2020)

Ivermectin: Panacea or true promise for COVID-19
por: Heimfarth, Luana, et al.
Publicado: (2020)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Ivermectin: Potential Role as Repurposed Drug for COVID-19
por: Dixit, Alok, et al.
Publicado: (2020)

Considerations on the article «antiviral and anti-inflammatory properties of ivermectin and its potential use in COVID-19»()
por: Hernández-Vásquez, Akram, et al.
Publicado: (2020)

Sofosbuvir for COVID-19 infection: A potential candidate
por: Gupta, Rohit, et al.
Publicado: (2020)

Off-label use of ivermectin for COVID-19: Are there any neuropsychiatric effects to be aware of?
por: O’Higgins, Marcelo G., et al.
Publicado: (2021)

Lessons Learned from Ivermectin
por: Watari, Takashi, et al.
Publicado: (2023)

A five-day course of ivermectin may reduce the duration of COVID-19 illness
por: Ahmed, Sabeena, et al.
Publicado: (2021)

Can Acetylcholine make you dream?
por: Singh, Alok, et al.
Publicado: (2019)

Commentary: Association between methylmalonic acid and cognition—A systematic review and meta-analysis
por: Balasundaram, Mahesh Kumar, et al.
Publicado: (2022)

The Effect of Ivermectin on Cases of COVID-19()
por: Annie, Frank H., et al.
Publicado: (2022)

Ivermectin as a potential treatment for COVID-19?
por: Chosidow, Olivier, et al.
Publicado: (2021)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Physician’s knowledge, attitude and practice of fixed drug combinations: Can we recognize the lacunae?
por: Singh, Alok, et al.
Publicado: (2022)

COVID 19: Are we fighting with the monster?
por: Singh, Alok
Publicado: (2020)

Opportunities to investigate the effects of ivermectin mass drug administration on scabies
por: Engelman, Daniel, et al.
Publicado: (2013)

Mendelian randomization reveals potential causal candidates for COVID-19 in 123 blood metabolites
por: Qiu, Shizheng, et al.
Publicado: (2022)

Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges
por: Popp, Maria, et al.
Publicado: (2022)

Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment
por: Seligmann, Hervé
Publicado: (2021)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Effects of COVID-19 lockdowns on PhD candidates
por: Hlongwa, Mbuzeleni
Publicado: (2020)

Istradefylline Versus Opicapone for “Off” Episodes in Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Singh, Alok, et al.
Publicado: (2021)

Finding Horcrux of psychiatric symptoms in COVID-19: Deficiencies of amino acids and vitamin D
por: Mehta, Arundhati, et al.
Publicado: (2021)

Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
por: Awad, Hoda, et al.
Publicado: (2022)

Association between ivermectin treatment and mortality in COVID-19: A hospital-based case-control study
por: Kirti, Ravi, et al.
Publicado: (2023)

Relative Awareness and Need of Dental Implant Treatment as applicable to Indian circumstances: An Overview
por: Sahoo, S, et al.
Publicado: (2014)

Internal jaw thrust for nasogastric tube insertion
por: Misra, Satyajeet, et al.
Publicado: (2018)

Protocol for teledentistry during COVID-19 in Armed Forces dental establishments
por: Chopra, Sukhbir Singh, et al.
Publicado: (2020)

Could nucleocapsid be a next-generation COVID-19 vaccine candidate?
por: Saldivar-Espinoza, Bryan, et al.
Publicado: (2022)

Psychological impact of ‘Lockdown’ due to COVID-19 pandemic in Nepal: An online survey
por: Gupta, Anoop Krishna, et al.
Publicado: (2020)

Prevalence of anxiety and depression among the healthcare workers in Nepal during the COVID-19 pandemic
por: Gupta, Anoop Krishna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_roof27kgm3s1q8bbpn9fucel9c